FOXO4-DRI
PreclinicalFOXO4-D-Retro-Inverso Peptide
- Category
- Longevity & Anti-Aging
- Aliases
- FOXO4-DRI, Proxofim
- Administration
- Subcutaneous injection (preclinical/animal research only)
Research and regulatory
Development stage
Preclinical research only; no human clinical trials completed as of 2026.
Legal and regulatory
Unregulated research compound; not FDA approved or reviewed for human use.
Side effects
Not characterized in humans; animal studies only